每年研究產出
每年研究產出
- 4結果
搜尋結果
-
2024
Corrigendum to “Risk factors of first and recurrent genitourinary tract infection in patients with type 2 diabetes treated with SGLT2 inhibitors: a retrospective cohort study” [Diabetes Res. Clin. Pract. 186 (2022) 109816] (Diabetes Research and Clinical Practice (2022) 186, (S0168822722006283), (10.1016/j.diabres.2022.109816))
Lin, Y. H., Lin, C. H., Huang, Y. Y., Tai, A. S., Fu, S. C., Chen, S. T. & Lin, S. H., 2024, (待刊) 於: Diabetes Research and Clinical Practice. 111925.研究成果: 期刊稿件 › 評論/辯論
-
Corrigendum to “Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study" [Endocrine Practice 30 (2024) 424-430]
Lin, Y. H., Lin, C. H., Lin, Y. C., Huang, Y. Y., Tai, A. S., Fu, S. C. & Lin, S. H., 09 2024, 於: Endocrine Practice. 30, 9, p. 898 1 p.研究成果: 期刊稿件 › 評論/辯論
-
2023
Sodium benzoate: A novel multi-target pharmaceutical approach to rescue clozapine-resistant schizophrenia.
Lin, C.-H. & Lane, H., 2023, 於: Schizophrenia Research. S0920-9964, 23, p. 171-178研究成果: 期刊稿件 › 評論/辯論
1 引文 斯高帕斯（Scopus） -
2022
Corrigendum: Ankle-Brachial Index Is Independently Associated With Cardiovascular Outcomes and Foot Ulcers in Asian Patients With Type 2 Diabetes Mellitus(Front. Endocrinol., (2021), 12, (752995), 10.3389/fendo.2021.752995)
Yang, M. C., Huang, Y. Y., Hsieh, S. H., Sun, J. H., Wang, C. C. & Lin, C. H., 16 03 2022, 於: Frontiers in Endocrinology. 13, 878492.研究成果: 期刊稿件 › 評論/辯論
開啟存取